SNP Genotyping Market Size (2024 - 2029)

SNP Genotyping Market Analysis

The SNP Genotyping Market is expected to register a CAGR of 21% over the forecast period.

The COVID-19 pandemic significantly impacted the SNP Genotyping market. Detecting SARS-CoV-2 variants with SNP genotyping and Genetic Analysis is boosting market growth. For instance, a research study by Helen Harper et al., published in PLOS ONE Journal in February 2021, found that PACE (PCR Allele Competitive Extension) SNP genotyping assays provide useful viral genotype identification for SARS-CoV-2 positive samples. The advantage of PACE-RT SNP genotyping technology is that the SNP panel can be modified at a low cost on a regular basis. With the emergence of several COVID-19 variants, the PACE-RT SNP genotyping approach could provide a useful tool for epidemiological surveillance and Genetic Variation Analysis. Owing to the increasing genotype research and development activities and bioinformatics in the development of diagnostic tools, such as Molecular Diagnostics, or effective therapeutics for COVID-19, the market is likely to continue its significant growth rate during the forecast period.

The major factors fueling the market growth are the miniaturization of equipment and instruments and increased multiplexing capacity leading to increased application. SNP technologies, extensively utilized in the Genetic Testing Industry, are used for detection and are beneficial in the etiology of several human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, among others. For instance, according to a study published by Elsevier in August 2021, SNP-based methods, a form of Molecular Genotyping, were compared and evaluated regarding their potential for integration in a miniaturized device. Regarding SNP-based methods, two approaches were explored in this study: real-time allele-specific PCR and HRM analysis, both significant in Genetic Marker Analysis. Allele-specific PCR was the best option for miniaturization since the results condensed to a presence/absence type of answer for the target allele, and it showed the best results for both pure and mixed varieties. Therefore, rising applications of SNPs in several life sciences and biotechnology aspects are driving the Genotyping Market.

Furthermore, the launch of new biological products, acquisitions, collaborations, and regional expansions are some of the strategic initiatives being taken by the companies to maintain stability in the Genotyping Assay Market. For instance, in October 2021, NRGene launched Soy SNPro. This is the first product in a line of optimized pre-designed SNP sets for genotyping (DNA Genotyping tests) of various crops that will significantly improve breeding program efficiency. This is likely to fuel market growth in the near future.

Therefore, the factors mentioned above are collectively responsible for the growth of the studied SNP Market over the forecast period. However, the lack of standardization in SNP processes and privacy concerns posing a threat to broad technology applications are the major factors hindering market growth.

SNP Genotyping Industry Segmentation

As per the scope of the report, single-nucleotide polymorphism (SNP) refers to mutations found at a specific locus or single base-pair mutation containing two alleles. SNPs aid in understanding the correlations between the genotype and behavior indicated by all living organisms. The SNP Genotyping Market is Segmented by Technology (TaqMan SNP Genotyping, Massarray SNP Genotyping, SNP GeneChip Arrays, and Other Techniques), End User (Pharmacogenomics and Diagnostic Field), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.